IMed Consultancy
Generated 5/9/2026
Executive Summary
IMed Consultancy is a UK-based regulatory and clinical consulting firm specializing in medical devices and in-vitro diagnostics (IVDs). Founded in 2010, the company provides expert services in CE marking, quality management systems, and global registrations, with a focus on compliance with evolving regulations such as the EU Medical Device Regulation (MDR) and In Vitro Diagnostic Regulation (IVDR). IMed acts as a flexible extension of clients' in-house teams, supporting market access in the UK, EU, US, and other global regions. The firm's deep expertise in navigating complex regulatory pathways positions it as a critical partner for medtech companies facing tightening compliance requirements. The consultancy benefits from strong tailwinds as the medical device industry adapts to the EU MDR and IVDR implementations, which are driving increased demand for regulatory support. With a lean operational model and no external funding, IMed has grown organically from its founding in 2010. While the firm operates in a competitive landscape, its specialization in both UKCA and EU MDR/IVDR gives it a unique niche. Overall, IMed Consultancy represents a steady-growth service business with recurring revenue potential, though scalability is limited by the consulting model. Conviction score: 65.
Upcoming Catalysts (preview)
- Q2 2027IVDR Certification Surge for Class D Devices80% success
- 2026UKCA Marking Requirements Post-Brexit70% success
- Q4 2027EU MDR Transition Period Expiration for Legacy Devices60% success
- · Pipeline Analysis
- · Competitive Landscape
- · Catalyst Calendar (full 12-month)
- · Bull Case
- · Bear Case
- · Counterfactual Scenarios
- · Valuation Notes
- · SEC Filing Highlights
- · Insider Activity
- · Literature Watch
- · Patent Landscape
- · Mechanism Cluster Map
- · Audio Briefing (5 min)